期刊文献+

顺铂联合吡柔比星对脑胶质瘤U87细胞株增殖的抑制作用 被引量:3

Inhibition effect of cis-diaminedichloroplatinum (CDDP) combined with pirarubicin(THP) on cell proliferation of brain glioma U87
暂未订购
导出
摘要 目的观察顺铂(CDDP)联合吡柔比星(THP)对脑胶质瘤U87细胞株增殖的抑制作用。方法采用MTT法检测不同浓度CDDP、THP以及两者联合应用时对U87细胞增殖作用的影响。结果随药物浓度增加,CDDP组、THP组和联合组对U87细胞增殖抑制作用逐渐增强(均P<0.01)。联合组对U87细胞增殖抑制率较同浓度CDDP组、THP组明显增加(P<0.05或P<0.01)。当CDDP和THP浓度为≤0.625μg/mL时,联合组Q值分别为1.72、1.31,两药联合应用具有协同作用,当CDDP和THP浓度≥1.25μg/mL时,联合组Q值分别为0.94、0.88、0.86、0.89,两药联合应用具有相加作用。结论 CDDP联合THP较单纯的CDDP或THP抑制U87细胞增殖作用更强,具有浓度依赖性。在较低剂量下就能达到明显肿瘤抑制效应,对杀伤U87细胞具有确切协同效应。 Objective To discuss inhibition effect of cis-Diaminedichloroplatinum (CDDP) combined with Pirarubicin (THP) on cell proliferation of brain glioma U87. Methods The MTT method was applied to detect the cell proliferation of brain glioma U87 in the influence by CDDP, THP and the combination of both under different concentration. Results As the concentration of drugs rose, the influences on inhibition of cell proliferation of brain glioma U87 in CDDP group, THP group and combination group were enhanced gradually (P〈0.01 on average). Compared with CDDP group and THP group under the same concentration, the inhibitory rate of cell proliferation obviously rose (P〈0.05 or P〈0.01). When the concentration in CDDP group and THP group was no more than 0.625μg/mL, the Q value in combination group were 1.72 and 1.31 respectively, which showed the coordination effect of combination of these two drugs. When the concentration in CDDP group and THP group was no less than 1.25txg/mL, the Q value in combination group were 0.94, 0.88, 0.86 and 0.89 respectively, which showed the additive effect of combination of these two drugs. Conclusion Compared with separate CDDP or THP, the combination of both CDDP and THP has more favorable inhibition of cell proliferation of brain glioma U87, with concentration dependent, which can achieve obviously tumor suppression effect under low dose, and has definitive coordination effect to kill and wound U87 cells.
出处 《中国现代医生》 2014年第15期1-3,共3页 China Modern Doctor
基金 浙江省中医药(中西医结合)重点学科建设项目(2012-XK-D01)
关键词 脑胶质瘤 顺铂 吡柔比星 增殖 Brain glioma MT]' Cis-Diaminedichloroplatinum(CDDP) Pirarubicins(THP) ProliferatiOn
  • 相关文献

参考文献20

  • 1Sathomsumetee,S,Rich JN.New approaches to primary brain tumor treatment[J].Anticancer Drugs,2006,17 (9):1003-1016.
  • 2尹宜发,杨凡,覃晓琳,周海波,刘朝奇.顺铂联合米托蒽醌调节脑胶质瘤U87细胞Sonic Hedgehog信号通路的研究[J].现代肿瘤医学,2011,19(7):1306-1309. 被引量:2
  • 3刘莺,曹婧,张艳玲,刘文静,李克,王居峰.依托泊甙联合顺铂治疗食管小细胞癌的疗效[J].肿瘤防治研究,2011,38(12):1423-1425. 被引量:2
  • 4金正均.合并用药中的相加[J].中国药理学报,1980,1(2):70-76.
  • 5Liu F,Liu S,He S,et al.Survivin transcription is associated with P-plycoprotein /MDRI overexpression in the multidrug resistance of MCF-7 breast cancer cells[J].Oncol Rep,2010,23 (5):1469-1475.
  • 6Sathornsumetee S,Rich JN,Reardon DA.Diagnosis and treatment of high-grade astrocytoma[J].Neurol Clin,2007,25(4):111-1139.
  • 7Nobuhiro Mikuni,Susumu Miyamoto.Surgical treatment for glioma:extent of resection applying functional neurosurgery[J].Neurol Med Chir(Tokyo),2010,50:720-726.
  • 8Deorah S,Lynch CF,Slib ebenaller ZA,et al.Trends in brain cancer incidence and survival in the United States:Surveillance,Epidemiology,and End Resultes Program,1973 to 2001[J].Neurosurg Focus,2006,20(4):347-351.
  • 9Zustovich F,Lombardi G,Della Puppa A,et al.A phase Ⅱ study of cisplatin and temozolomide in heavily pretreated patients with temozolomide-refractory high-grade malignant glioma[J].Anticancer Res,2009,29 (10):4275-4279.
  • 10Natsume A,Ishii D,Wakabayashi T,et al.IFN-beta downregulates the expression of DNA repair gene MGMT and sensitizes resistant glioma cells to temozolomide[J].Cancer Res,2005,65(17):7573-7579.

二级参考文献54

  • 1孙彦辉,张亚卓,王忠诚,孙梅珍,赵东海.MGMT在脑胶质瘤组织中的表达及其与患者生存期的关系[J].癌症,2004,23(9):1052-1055. 被引量:36
  • 2梅文忠,陈锦锋,何理盛.谷胱甘肽S转移酶л在脑原发性胶质瘤中表达的临床意义[J].福建医药杂志,2004,26(4):117-118. 被引量:2
  • 3袁中玉,管忠震,周中梅,夏奕,黄万钟,杨秀丽.53例肺外小细胞癌的临床分析[J].癌症,2006,25(9):1131-1133. 被引量:12
  • 4吴慧,李善泉,万杰青,戴炯,朱志安.替尼泊甙加司莫司汀联合化疗对术后脑胶质瘤的疗效分析[J].中国临床神经外科杂志,2006,11(12):755-756. 被引量:6
  • 5金正均.合并用药中的相加[J].中国药理学报,1980,1:70-73.
  • 6Abe T, Mori T, Wakabayashi Y, et al. Expression of multidrug resistance protein gene in patients with glioma after chemotherapy. J Neurooncol, 1998, 40:11-18.
  • 7Toth K, Vaughan MM, Peress NS, et al. MDR1 P-glycoprotein is expressed by endothelial cells of newly formed capillaries in human gliomas but is not expressed in the neovasculature of other primary, tumors. Am J Pathol,1996,149 :853-858.
  • 8Brell M, Tortosa A, Verger E, et al. Prognostic significance of 06-methylgnanine-DNA methyhransferase determined by promoter hypermethylation and expression in anaplastic gliomas. Clin Cancer Res, 2005,11:5167-5174.
  • 9Taniguchi K, Wakabayashi T, Yoshida T, et al. Immunohistochemical staining of DNA topoisomerase Ⅱalpha in human gliomas. J Neurosurg, 1999,91:477-482.
  • 10Miettinen HE, Jarvinen TA, Kellner U, et al. High topoisomerase Ⅱalpha expression associates with high proliferation rate and and poor prognosis in oligodendrogliomas. Neuropathol Appl Neurobiol,2000, 26:504-512.

共引文献21

同被引文献45

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部